ASX Announcements

9 January 2022

Application for quotation of securities

Securities issued as part of transactions previously announced.

9 January 2022

Update to application for quotation of securities

Update to previous announcement.

24 January 2022

LCT signs Service Agreement with NZeno, secures pig cells for NTCELL trial

31 January 2022

Quarterly Activities Report/Appendix 4C - December Quarter 2021

25 February 2022

Half Yearly Report and Accounts

The half-year to 31 December 2021 saw further advances concerning the company’s plans for a third clinical trial of NTCELL in Parkinson’s disease, a disease affecting more than 10 million people worldwide.